Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Two out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading down 14 points (-0.1%) at 16,140 as of Tuesday, Feb. 18, 2014, 12:00 PM ET. The NYSE advances/declines ratio sits at 2,063 issues advancing vs. 873 declining with 164 unchanged. The Real Estate industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was St. Joe Corporation ( JOE), up 2.4%. Top gainers within the industry include E-House China Holdings ( EJ), up 4.0%, Icahn ( IEP), up 2.4%, Two Harbors Investment ( TWO), up 1.7%, Howard Hughes ( HHC), up 1.5% and Brookfield Asset Management ( BAM), up 1.5%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Omega Healthcare Investors ( OHI) is one of the companies pushing the Real Estate industry lower today. As of noon trading, Omega Healthcare Investors is down $0.46 (-1.5%) to $30.95 on average volume. Thus far, 514,191 shares of Omega Healthcare Investors exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $30.78-$31.60 after having opened the day at $31.55 as compared to the previous trading day's close of $31.41. Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. Omega Healthcare Investors has a market cap of $3.9 billion and is part of the financial sector. Shares are up 5.4% year-to-date as of the close of trading on Friday. Currently there is 1 analyst that rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and increase in stock price during the past year. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Omega Healthcare Investors Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.